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Summary 
Pancreatic islets, also called islets of Langerhans, are clusters of (3 -cells that 
produce glucose-level-controlling insulin. If the body has an autoimmune response to 
these (3 -cells and begins destroying them, Type I diabetes (insulin-dependent) results. 
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Transplantation of healthy islets into the body has been a measure that has proven to be 
successful at treating diabetes. Transplantation ofthe islets has occurred using naked 
islets and encapsulated islets. Naked islets require immunosuppression, whereas 
encapsulated islets are protected from the immune system. 
Islets are encapsulated using a wide variety ofbiocompatible polymer systems. 
Calcium alginate is one of many natural polysaccharides that are used in encapsulating 
islets. The commercially available form of alginate is sodium alginate which, when 
added to water, forms a viscous liquid mixture. When the islet cells are added to this 
viscous liquid and the mixture is dropped into a solution containing calcium chloride, 
gelled beads are formed. Cells are trapped in the beads formed, providing a protective 
barrier for the cells. 
This project's goal is to investigate the use of this protective coating as a way of 
sustaining the activity of the islets during transportation from digestion location to 
transplantation location. A genetically engineered bioluminescent bacterium designated 
PM6 was chosen as an initial model system in order to determine if the removal of the 
cells from the encapsulation material would be likely to cause damage to the cells. 
PM6 produces light during its normal growth phase with the ability to act as an 
instantaneous indication of cellular activity. PM6 was encapsulated in gel beads using 
calcium alginate. Later, the cells were removed from encapsulation by placing the beads 
in a solution of sodium chloride. The cell density and light emitted by previously 
encapsulated PM6 was compared to that ofPM6 grown under liquid culture conditions. 
The lag phase is slightly longer for the encapsulated cells, but the time dependent cell 
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density and light emission by the previously encapsulated bacteria are essentially the 
same as that of unencapsulated PM6. 
The next step of this project is to look at the stabilizing effects of removing 
immortalized endothelial kidney cells from the calcium alginate. These cells are 
considered more sensitive than the bacteria used in this initial study but are easier to 
maintain in culture than islets. If positive results are obtained for the kidney cells, the 
study will proceed to the pancreatic islet cell line. 
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Background 
Pancreatic Islets 
Pancreatic islets are often referred to as the islets of Langerhans. These islets are 
clusters of insulin producing and secreting {3 -cells found in the pancreas. Insulin is the 
hormone necessary to regulate the glucose level within the body. When these {3 -cells are 
destroyed by an autoimmune response, the body becomes insulin deficient. This disease 
is known as Type I diabetes and accounts for five to ten percent of the diagnosed cases of 
diabetes in the United States. l The number of people that suffer from Type I diabetes is 
approximately 0.85 - 1.7 million. l The most prevalent treatment for Type I diabetes is 
through some form of insulin dosage. Insulin must be administered daily, either through 
numerous injections or by an insulin pump, in order to control the blood-glucose level. 
Secondary complications, such as nephropathy, neuropathy, and cardiovascular 
problems2, can be prevented by intense insulin therapy; however, patients taking insulin 
have an increased risk in experiencing hypoglycemic episodes. 
Isolation of Pancreatic Islets 
Warnock and Rajotte first developed the method of isolating pancreatic islets, and 
Lanza et al. later modified the method.3.4 The pancreas is injected with cold University 
of Wisconsin organ preservation solutionS and removed from the body. The organ is then 
injected with a crude solution of collagenase via the pancreatic duct system. The enzyme 
digests the pancreas, and the dissociated tissue is washed with cold medium. Utilizing 
the density difference between the islets and the exocrine tissue, the islets are separated, 
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collected, and washed several times. The separated islets are placed in either an ex -MEM 
or Hams Fl2 based medium. The compact appearance of the islets is regained after 
approximately 24-48 hours in culture. 
Encapsulation and Transplantation of Pancreatic Islets 
Whole organ transplantation of the pancreas requires an extensive surgical 
procedure? Therefore, it is desirable to only transplant the insulin-producing islets. 
Encapsulation of the islets into a biocompatible polymer that continue to allow the 
secretion of insulin has been successful in sustaining normoglycemia. Due to the large 
volume of the encapsulated islet grafts, the peritoneal cavity was designated as the ideal 
transplantation site.2 A small incision is made in the abdomen, and the encapsulated 
islets are transplanted to the cavity. Encapsulation eliminates the need for 
immunosuppression, and transplantation in the peritoneal cavity reduces the risks 
associated with a full organ transplant. However, most of the islet transplants are still 
performed using naked islets because of the lack of government approval for 
encapsulated islets. 
During transportation from the digestion location to the transplantation site, the 
activity of some of the islets is lost due to unknown causes. These causes could be 
extreme temperature variation or even shock and stress experienced while in transit. The 
objective of this project is to determine if encapsulating the islets in a biocompatible 
material will retain the activity of the islets during transportation. The basis of this 
biocompatible material will be alginate. 
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Alginate 
Alginate is an anionic polysaccharide derivative of brown seaweed. Alginates 
have hydro-gel forming properties with many di-, tri-, or multivalent cations. A semi 
permeable gel is formed when the alginate gel is cross-linked with one of these cations. 
Because of its mild gelling and good biocompatibility, alginate gel has long been used in 
the food and pharmaceutical industries.? Alginates are linear copolymers of 1,4-linked 
cx-L-guluronic acid (G) and {3-D-mannuronic acid (M) arranged as chains in alternating 
block wise patterns.8 The relative amounts of guluronic and mannuronic acid in the 
alginate has a significant impact on porosity, swelling behavior, stability, biodegradation 
ability, gel strength, immunolgoical characteristics, biocompatibility, and diffusion. 
Bioluminescent Bacterium Designated PM6 
Due to the lack of availability of pancreatic islet cells, the preliminary studies to 
determine if the encapsulation and separation processes were harmful were performed on 
a surrogate cell line. This cell line is a bioluminescent bacterium designated PM6 that 
was created by researchers at Syracuse University. The bacterium is a genetically 
modified bacterium that is derived from a Pseudomonad strain isolated in activated 
sludge. The activated sludge microorganisms were mated with E. coli carrying the 
pUTK2 plasmid. The pUTK2 plasmid contains a lux transposon and a tetracycline 
resistant gene. The lux transposon contains the five genes necessary to catalyze light and 
a constitutive promoter, which allows the bacterium to produce light under normal 
conditions. 
The reason this bacterium was chosen is because it is widely available in the 
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laboratory, and other researchers working in the laboratory are familiar with growth and 
assay procedures for PM6. Since the bacterium emits light under normal growing 
conditions, this characteristic could be utilized in an assay that determines if the bacteria 
survived the encapsulation and separation procedure. 
Work Performed 
Equipment and Materials Used 
The cell density of the PM6 bacteria was determined using a Beckman 
spectrophotometer DU520 at a wavelength of 600 nm. The light emission was measured 
using a Sirius Luminometer. An Innova 4000 (New Brunswick Scientific) 
incubator/shaker was used to grow the PM6 in culture. A 1.8% w/v solution of alginic 
acid, sodium salt (Sigma-from macrocystis pyrifera (Kelp) low viscosity [9005-38-3]) 
in distilled water was the source of the alginate, and a 0.05 M solution calcium chloride 
(Fischer Scientific) in distilled water served as the divalent cation used in the hydro-gel 
bead formation. A 2.0 M solution of sodium chloride (Fischer Scientific) distilled water 
was the source of the sodium ions to break the cross-linking between calcium and 
alginate. The sodium chloride and calcium chloride solutions were pH adjusted using 
hydrochloric acid and sodium hydroxide. Difco nutrient broth (Becton Dickinson) 
prepared according to the instructions of the manufacturer was the growth medium used 
in growing the PM6. A 2.5 g/200 mL solution of tetracycline was also used in the growth 
of the bacteria. The bacterium has a tetracycline resistance gene, and the presence of 
tetracycline allows the growth of the bacteria in pure culture. 
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Production of a Growth and Light Emission Curve for 
Unencapsulated PM6 
Unencapsulated PM6 was fIrst grovm to determine a growth and light emission 
curve in normal liquid culture. 100 fLL of frozen PM6 was transferred to a I L flask 
containing 100 mL of an 8 giL solution of nutrient broth. 80 fLL of a 2.5 mgl 200 mL 
solution of tetracycline was added to the flask. The flask was placed in the 
incubator/shaker at 30°C and 200 rpm Cell density and light emission readings were 
obtained every 15 minutes starting at approximately 4.5 hours from inoculation. 
Readings were taken until the optical density of the solution reached 2.6-2.8. 
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Figure 1: Cell density and light emission curves for unencapsulated PM6 at 30°C and 
200 rpm. 
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Encapsulation of PM6 Using Calcium Alginate 
PM6 was grown in liquid culture following the previously mentioned procedure. 
When the cells had reached an OD600nm of approximately 0.9-1.0, the cells were cooled 
to 4°C. 2 mL of the refrigerated cells were spun down and activated using I mL offresh 
8 giL nutrient broth for 20 minutes. After the activation time had expired, the cells were 
spun down and 500 /1L of alginate was added to the micro centrifuge tube. The mixture 
was agitated to ensure the cell pellet had dissolved in the alginate. 
The source of alginate used in this project was alginic acid. The divalent cation 
used as the cross linking agent was Ca2+, obtained from the compound calcium chloride. 
Gel beads containing encapsulated PM6 were made by dropping this 500 /1L of 1.8% 
w/v solution of sodium alginate containing spun down PM6 (2 mL of OD600 nm 
refrigerated cells) from a 5 cc syringe and 23 G I" needle into a ISO mL solution of 0.05 
M calcium chloride. The divalent Ca2+ cross links the alginate immediately to form a gel 
bead containing encapsulated PM6. The beads and calcium chloride are stirred at 300 
rpm for approximately 5 minutes to allow complete gelation. 
2 Na(Alginate) + Ca2+ -7 Ca(Alginate)2 + 2 Na + 
The gel beads were then removed from the calcium chloride solution by 
decantation. The gel beads were placed in 200 mL of a 2.0 M solution of sodium 
chloride. The sodium chloride and gel beads were stirred at 600 rpm until the PM6 
separate from the gel beads. The first data set below represents a 4.5-hour interaction 
time between the encapsulated PM6 and the 2.0 M sodium chloride solution. The second 
set of data below represents a 2-hour interaction time between the encapsulated PM6 and 
the sodium chloride. Once the cells have separated from the gel beads, the solution is 
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centrifuged for 25 minutes at 12000 rpm. The sodium chloride is decanted from the 
sodium alginate and PM6 remaining at the bottom of the centrifuge bottle. 100 mL of an 
autociaved 8 gIL solution of nutrient broth containing 80 ~L of 2.5 g/200 mL 
tetracyciine was transferred to the centrifuge bottle. The solution was agitated to ensure 
the PM6 and gel were returned to a homogeneous mixture with the nutrient broth. 
Production of a Growth and Light Emission Curve for 
Encapsulated PM6 
The nutrient broth, sodium alginate, and PM6 solution were transferred to aiL 
flask and placed in the incubator/shaker at 30°C and 200 rpm. Light emission and optical 
density readings were taken for the solution. 
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Figure 2: Cell density and light emission curve for previously encapsulated PM6 at 30°C 
and 200 rom, 4.5 hour sodium chloride interaction. 
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Figure 2: Cell density and light emission curve for previously encapsulated PM6 at 30°C 
and 200 rpm, 2 hour sodium chloride interaction. 
Discussion of Results 
The encapsulation and separation procedure used with bioluminescent bacterium 
PM6 did not inhibit light production or growth. The previously encapsulated bacteria 
exhibited cell density and light emission values similar to those of unencapsulated 
bacteria, which can be noted from a comparison of Figure 1 and Figure 2. The previously 
encapsulated bacteria were carefully examined under a microscope to determine ifthe 
bacteria were present in the same form as that of unencapsulated bacteria. The cells 
appeared to be the same as that of unencapsulated bacteria. If the cells were damaged in 
the process, one would have expected the cells to neither produce light nor grow. 
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The interaction time is a significant factor in the lag time of the bacteria. A 4.5-
hour interaction produced an approximately 18 hour lag phase, whereas a 2-hour 
interaction time resulted in approximately a 7.5 hour lag phase. This is most likely due to 
an extreme osmotic pressure gradient caused by the high salt concentration. 
Recommendation for Future Work 
The next cell line that needs to be studied is immortalized endothelial kidney 
cells. These cells are readily available within the University of Tennessee Center for 
Biotechnology. The kidney cells would be more sensitive than the bacteria used in this 
study, and would provide one additional stepping-stone before encapsulation and 
separation of primary pancreatic islets, which are more difficult to obtain and culture, are 
examined. The form of alginic acid used in future experiments should be one that has 
been purified and is preferably of a higher guluronic acid content because the guluronic 
and mannuronic acid ratio directly affects the diffusion properties of the bead.8 The 
composition of the alginate affects diffusion, which will become a significant factor in 
retaining the cell's activity while encapsulated. Information regarding key factors that 
degrade the activity of the islets during transportation should be obtained. One may find 
that encapsulation will not prevent the determined factors from negatively affecting the 
activity. A source of primary islets must also be determined in order for the study to 
proceed past the endothelial kidney cell line. 
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Increasing the Stability of 
Pancreatic Islets 
J. Brock Thomas 
B.S. Chemical Engineering May 2003 
Mentor: Dr. Paul Frymier 
Pancreatic Islet Cells 
+Referred to as Islets of Langerhans 
+Beta cells that secrete insulin when the 
body experiences an increase in the 
glucose level 
+The destruction of these cells by an 
autoimmune response results in Type 1 
Diabetes (Insulin-Dependent) 
Isolation of Pancreatic Islets 
+The pancreas is infused with University 
of Wisconsin organ preservation 
solution 
+ The organ is removed from the body 
and infused with a crude solution of 
collagenase 
+The islets are collected using density 
based purification and placed in tissue 
culture 
Islet Transplantation 
• The isolated islets are transplanted into the 
peritoneal membrane 
• The immune system is suppressed to prevent 
rejection of the cells 
Bioartifical Pancreas 
• Entrapment of the isolated cells in a 
biocompatible polymer system 
• Transplantation of the entrapped islets does 
not require immunosuppression 
Objective of Project 
• Increase the survival rate of the isolated islets 
during transportation from point of digestion 
to pOint of transplantation 
• Utilize the method used to encapsulate islets 
for bioartificial transplantation to maintain the 
functionality during transportation 
• Exhibit that the cells retain their activity when 
removed from their protective encapsulation 
material 
Alginate 
+Serves as the biocompatible 
encapsulation material 
+Gels under mild physiological conditions 
+Naturally occurring polysaccharide 
found in brown algae 
+Available commercially as alginic acid or 
sodium alginate 
Gelling Procedure 
• 20/0 w Iv sodium alginate is dropped approximately 10 
em from a syringe and needle into alSO mL 0.05 M 
solution of CaCI2 
• The polymer is cross-linked to form a gel bead 
• 2 Na(Alginate) + Ca++ -7 Ca(Alginate)2 + 2 Na+ 
Cell Separation 
• The beads are removed from the CaCI2 after 5 minutes 
and placed in a 200 mL 2.0 M solution of NaCI 
• The reverse of the above reaction occurs, and the 
encapsulated cells fall out of the gel solution after 
approximately one hour 
• The mixture is centrifuged to separate the NaCI from the 
remaining gel and cells 
Cell Lines 
.. PM6 Bioluminescent Bacteria 
• Determine if cell separation method destroys cells 
• Positive results will indicate the ability of the cells 
to grow and product light after gelling, separation, 
and cultue 
.. Endothelial Kidney Cells 
• Continue to determine if cell separation method 
destroys cells 
• Positive results will indicate the ability of the cells 
to reattach after gelling, separation, and culture 
Cell Lines (continued) 
+Pancreatic Islet Cells 
• Continue to determine if cell separation 
method destroys the activity of the cells 
• Positive results will indicate the ability of 
the cells to produce insulin after gelling, 
separation, and culture 
• Determine if encapsulation provides 
stability against the elements encountered 
during transportation 
PM6 Bioluminescent Bacteria 
+Created through directed evolution 
+Contains the luxtransposon which 
catalyzes light-producing reactions 
+Emits bioluminescence under normal 
growing conditions 
Cell Inoculation and Growth 
+100 uL of frozen PM6 cells are 
innoculated into 100 mL of 8 mg/mL 
nutrient broth 
+The innoculated cells are then 
incubated and shaken at 30°C 
+The growth of the bacteria and light 
emmittance is exhibited in Figure 1 
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Immobilized Cells Results 
• 2 mL of refrigerated PM6 with an 00 of 0.9 was spun 
down and mixed with 500 uL of sodium alginate 
• The PM6 cells and sodium alginate were gelled 
• The cells were removed out of encapsulation using 
sodium chloride and placed in growth medium 
• Figure 2 represents the growth curve and light 
emitted for PM6 after having been encapsulated and 
released from the calcium alginate 
• Lag phase is increased, but growth and light emitted 
follows the same pattern as cultured cells 
Figure 2: Growth Curve and Light Emitte 
for Encapsulated PM6 
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Conclusions 
.. Gelling and separation of cells does not 
destroy the activity and the viability of the 
PM6 bioluminescent bacteria 
.. Encapsulated cells exhibit similar growth and 
light emitted patterns as those that are 
cultured 
.. Endothelial kidney cells will now be 
encapsulated to determine if a more sensitive 
cell line can withstand the cell separation step 
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Figure I: Cell density and light emission curves for unencapsulated PM6 at 30°C and 
200 rpm. 
Encapsulation of PM6 Using Calcium Alginate 
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